Ludwig San Diego
AT EVERY STEP OF THE RESEARCH PROCESS FROM THE LAB TO THE CLINIC, WE ARE PURSUING INNOVATIVE WAYS TO PREVENT AND CONTROL CANCER.
Scientists show how targeted drug can reverse the effects of certain immune cells that suppress responses to cancer immunotherapy. The drug they use in their studies is already in early-stage clinical trials.
Researchers demonstrate that GBM cells import vast amounts of cholesterol to survive and that the mechanisms they use to do so can be undermined with drug-like molecules currently in clinical development.
The findings have implications for cancer immunotherapy and the treatment of a number of autoimmune and inflammatory diseases.